Abstract:Phenotypic and genotypic heterogeneity in congenital ocular diseases, especially in anterior segment dysgenesis (ASD), have created challenges for proper diagnosis and classification of diseases. Over the last decade, genomic research has indeed boosted our understanding in the molecular basis of ASD and genes associated with both autosomal dominant and recessive patterns of inheritance have been described with a wide range of expressivity. Here we describe the molecular characterization of a cohort of 162 patients displaying isolated or syndromic congenital ocular dysgenesis. Samples were analyzed with diverse techniques, such as direct sequencing, multiplex ligation-dependent probe amplification, and whole exome sequencing (WES), over 20 years. Our data reiterate the notion that PAX6 alterations are primarily associated with ASD, mostly aniridia, since the majority of the cohort (66.7%) has a pathogenic or likely pathogenic variant in the PAX6 locus. Unexpectedly, a high fraction of positive samples (20.3%) displayed deletions involving the 11p13 locus, either partially/totally involving PAX6 coding region or abolishing its critical regulatory region, underlying its significance. Most importantly, the use of WES has allowed us to both assess variants in known ASD genes (i.e., CYP1B1 , ITPR1 , MAB21L1 , PXDN , and PITX2 ) and to identify rarer phenotypes (i.e., MIDAS, oculogastrointestinal-neurodevelopmental syndrome and Jacobsen syndrome). Our data clearly suggest that WES allows expanding the analytical portfolio of ocular dysgenesis, both isolated and syndromic, and that is pivotal for the differential diagnosis of those conditions in which there may be phenotypic overlaps and in general in ASD.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the diagnostic and classification challenges brought by phenotypic and genotypic heterogeneity in congenital ocular dysplasia diseases, especially in anterior segment dysgenesis (ASD). Specifically, the authors conducted molecular characterization analysis on 162 patients with isolated or syndromic congenital ocular dysplasia by using whole exome sequencing (WES) technology. The research aims to: 1. **Evaluate the role of the PAX6 gene in ASD**: The PAX6 gene is considered one of the main genes associated with ASD, especially in aniridia. The study evaluated the variation of the PAX6 gene and its regulatory regions through methods such as direct sequencing, multiplex ligation - dependent probe amplification (MLPA), and WES. 2. **Identify variations in other known ASD - related genes**: In addition to the PAX6 gene, the study also evaluated variations in other genes known to be associated with ASD (such as CYP1B1, ITPR1, MAB21L1, PXDN, and PITX2) to expand the scope of ASD analysis. 3. **Discover rare phenotypes**: Through WES, researchers hope to identify some rare phenotypes that may be associated with other complex syndromes, such as MIDAS syndrome, gastrointestinal neurodevelopmental syndrome, and Jacobsen syndrome. 4. **Improve the diagnosis rate**: By using WES, the study hopes to improve the diagnosis rate of ASD patients, especially in cases where phenotypes overlap. WES can provide more accurate molecular diagnosis, which is helpful for the differential diagnosis of diseases. ### Main findings - **Variations in the PAX6 gene**: The study found that 66.7% of the samples had pathogenic or potentially pathogenic variations at the PAX6 gene locus, and 20.8% of the positive samples showed deletions involving the 11p13 locus, which partially or completely affected the PAX6 coding region or its key regulatory regions. - **Variations in other ASD - related genes**: WES found pathogenic or potentially pathogenic variations in other ASD - related genes in PAX6 - negative samples, including genes such as PITX2, PXDN, FZD5, MAB21L1, and ITPR1. - **Identification of rare phenotypes**: The study also found some rare phenotypes associated with complex syndromes, such as MIDAS syndrome and gastrointestinal neurodevelopmental syndrome. ### Conclusion By using WES technology, the study not only confirmed the important role of the PAX6 gene in ASD, but also expanded the scope of analysis of ASD - related genes and improved the diagnosis rate of ASD patients, especially in cases where phenotypes overlap. This provides an important molecular basis for the clinical diagnosis and treatment of ASD.

A bird's eye view on the use of whole exome sequencing in rare congenital ophthalmic diseases

Deciphering the etiology of undiagnosed ocular anomalies along with systemic alterations in pediatric patients through whole exome sequencing

Novel molecular, structural and clinical findings in an Italian cohort of congenital cataract

[Application of whole exome sequencing technology in the diagnosis of hereditary eye diseases]

A Copernican Revolution of Multigenic Analysis: A Retrospective Study on Clinical Exome Sequencing in Unclear Genetic Disorders

Clinical use of whole exome sequencing in children with developmental delay/intellectual disability

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Reverse Phenotyping after Whole-Exome Sequencing in Children with Developmental Delay/Intellectual Disability—An Exception or a Necessity?

The impact of the European Society of Cardiology guidelines and whole exome sequencing on genetic testing in hereditary cardiac diseases

Identification of novel pathogenic variants and novel gene-phenotype correlations in Mexican subjects with microphthalmia and/or anophthalmia by next-generation sequencing

Ultra-rare renal diseases diagnosed with whole-exome sequencing: Utility in diagnosis and management

Phenotype Driven Analysis of Whole Genome Sequencing Identifies Deep Intronic Variants that Cause Retinal Dystrophies by Aberrant Exonization

Application of Whole Exome and Targeted Panel Sequencing in the Clinical Molecular Diagnosis of 319 Chinese Families with Inherited Retinal Dystrophy and Comparison Study.

Whole Exome Sequencing as a First-Line Molecular Genetic Test in Developmental and Epileptic Encephalopathies

Genetic and phenotypic analysis of 225 Chinese children with developmental delay and/or intellectual disability using whole-exome sequencing

Diagnostic genome sequencing improves diagnostic yield: a prospective single-centre study in 1000 patients with inherited eye diseases

The Oculome Panel Test: Next-Generation Sequencing to Diagnose a Diverse Range of Genetic Developmental Eye Disorders

Whole genome sequencing and in vitro splice assays reveal genetic causes for inherited retinal diseases

Case report: Early use of whole exome sequencing unveils HNRNPU-related neurodevelopmental disorder and answers additional clinical questions through reanalysis

The Systemic Genotype-Phenotype Characterization of PAX6-Related Eye Disease in 164 Chinese Families

Clinical application of whole-exome sequencing across clinical indications